Peesh Foundation will award treatment grants of up to Rs 10 Lakhs for Spinocerebellar Ataxia and Body Dysmorphic Disorder -related treatment.
To contribute toward the betterment of society, Peesh Chopra, MD of the US-based Peesh Venture Capital (PVC) that invests in disruptive technologies has announced the launch of Peesh Foundation with Rs 60 crore funds to support research and development and to fight incurable disorders like Spinocerebellar Ataxia and Body Dysmorphic Disorder (BDD).
Spinocerebellar ataxia (SCA) or also known as Spinocerebellar Atrophy or Spinocerebellar degeneration, is a progressive, degenerative, genetic disease with multiple types, each of which could be considered a disease in its own right. An estimated 500,000 people in India are diagnosed with Spinocerebellar Ataxia.
“From children to busy mothers, Spinocereballar Ataxia and Body Dysmorphic Disorder can affect people of all ages, from all walks of life. We are committed to helping every person living with ataxia and body dysmorphic disorder to take control of their disease,” says Sunita Chopra, Executive Director, Peesh Foundation. “Through our research grants and treatment grants, we not only help fund research to find better treatment options and an eventual cure for this disease, but we also show communities the incredible diversity of people affected by Spinocerebellar ataxia and Body Dysmorphic Disorder.”
Peesh Foundation has been established to find solutions and treatments for such incurable disorders and will award seed grant of up to Rs 10 Lakh for Spinocerebellar Ataxia and Body Dysmorphic Disorder -related research projects. Grants of up to Rs 20 Lakh will be considered for early or pilot phases of studies and ongoing investigations.
“Peesh Foundation will award treatment grants of up to Rs 10 Lakhs for Spinocerebellar Ataxia and Body Dysmorphic Disorder -related treatment. For both Spinocerebellar Ataxia and Body Dysmorphic Disorder, patients must have a professional diagnosis from a reputed healthcare institution,” stated the official release.